Seroquel

Seroquel

Dosage
25mg 50mg 100mg 200mg 300mg
Package
360 pill 180 pill 120 pill 90 pill 60 pill 30 pill
Total price: 0.0
  • Seroquel (quetiapine) is normally dispensed in pharmacies with a prescription in most countries; while some pharmacies or suppliers may sometimes sell tablets without checking a prescription or receipt, obtaining prescription-only medicines without a valid prescription is unsafe and may be illegal — always consult a prescriber or pharmacist.
  • Seroquel is used to treat schizophrenia, acute bipolar mania, bipolar depression and as an adjunct for major depressive disorder; it is an atypical (second‑generation) antipsychotic that primarily antagonises dopamine D2 and serotonin 5‑HT2A receptors (with additional antihistamine H1 and alpha‑1 adrenergic effects contributing to sedation and orthostatic hypotension).
  • Usual doses vary by indication: schizophrenia adults often target 300–400 mg/day (start ~25 mg twice daily titrated up); acute bipolar mania may be increased to ~400 mg/day by Day 4 (max 800 mg/day); bipolar depression commonly titrated to 300 mg at bedtime (max 300 mg); adjunctive use in MDD often 50 mg XR at bedtime titrated to 150–300 mg XR (max 300 mg); paediatric, elderly and hepatic impairment require lower starting doses and slower titration.
  • Administered orally as immediate‑release tablets (25–400 mg strengths) or extended‑release (XR) tablets (50–400 mg strengths); no injectable, liquid or topical forms are available — do not crush or chew XR tablets.
  • Onset: sedative effects can occur within 1–3 hours after a dose; therapeutic antidepressant or antipsychotic effects usually begin over days to weeks, with full response often taking several weeks.
  • Duration of action: immediate‑release dosing effects are generally shorter (coverage over the dosing interval, often requiring twice‑daily dosing), whereas XR is formulated for once‑daily dosing with clinical coverage across 24 hours; the elimination half‑life of quetiapine is roughly 6 hours (individual variation and metabolites affect duration).
  • Alcohol warning: avoid alcohol while taking seroquel — alcohol increases sedation, dizziness and the risk of respiratory depression and orthostatic hypotension, and can worsen side effects.
  • The most common side effect is drowsiness/sedation (other frequent effects include dizziness, dry mouth, weight gain, constipation and orthostatic hypotension).
  • Would you like to try seroquel without a prescription? I can’t help you obtain prescription medication without a valid prescription — if you’re considering this treatment I can help you find information on talking to a doctor or pharmacist and on safe, legal access to care.
Trackable delivery 5-9 days
Payment method Visa, MasterCard, Discovery, Bitcoin, Ethereum
Free delivery (by Standard Airmail) on orders over €172.19

Basic Seroquel Information

  • INN (International Nonproprietary Name): Quetiapine
  • Brand Names Available In Canada (English): Seroquel; Seroquel XR
  • ATC Code: N05AH04 — Atypical (second‑generation) antipsychotic
  • Forms & Dosages: Immediate‑release tablets 25 mg–400 mg; Extended‑release (XR) tablets 50 mg–400 mg
  • Manufacturers In Canada (English): AstraZeneca (originator); multiple generics available from manufacturers such as Teva, Sandoz, Mylan and others
  • Registration Status In Canada (English): Marketed in Canada as Seroquel and Seroquel XR; prescription‑only
  • OTC / Rx Classification: Prescription (Rx) only

Latest Research Highlights

Worried about new safety signals or whether quetiapine still works the way it used to?

Regulatory approvals and product labels confirm quetiapine is effective for schizophrenia, bipolar disorder and as adjunctive therapy in major depressive disorder.

Clinical trial programmes and decades of use support symptomatic benefit for acute mania and psychosis, and adjunct benefit in treatment‑resistant depression when combined with an antidepressant.

Recent literature emphasises metabolic effects, sedation and dose‑related cognitive slowing as consistent concerns across populations.

Special populations such as older adults show reduced tolerability and increased risk when used for dementia‑related agitation, aligning with Health Canada and international safety statements.

Trial Endpoint Summary From Available Sources NNT Common Adverse Events
Schizophrenia Efficacy Demonstrated symptom reduction versus placebo in registration trials and real‑world use. Not specified Drowsiness, weight gain, orthostatic hypotension
Acute Bipolar Mania Shown effective for acute mania with relatively rapid titration schedules used in trials. Not specified Somnolence, tachycardia, dry mouth
Bipolar Depression XR dosing to ~300 mg at bedtime demonstrates antidepressant effect for bipolar depression. Not specified Weight gain, metabolic changes, sedation
Adjunctive MDD XR formulation used as adjunct; labelled dosing up to 300 mg nightly. Not specified Increased appetite, lipid/glucose changes

Top Trial Takeaways:

  • Quetiapine has reproducible efficacy across schizophrenia and bipolar spectrum disorders.
  • Extended‑release formulations streamline once‑daily dosing for depressive indications.
  • Metabolic adverse effects (lipids, weight, glucose) are consistently reported.
  • Sedation is dose dependent and contributes to falls and cognitive slowing, especially in older adults.
  • Population stewardship is shifting against routine low‑dose use for insomnia because of safety signals.

Data‑Highlight: Canadian registry incidence rates for specific adverse events are not specified in the available product information.

Clinical Effectiveness In Canada

Can quetiapine be relied upon for major mood and psychotic disorders in Canadian practice?

Health Canada–level positioning matches international labels: quetiapine is indicated for schizophrenia, bipolar disorder and as adjunctive therapy in major depressive disorder.

Seroquel and Seroquel XR are the marketed branded forms in Canada, and generics are widely used in community dispensing.

Indication Typical Coverage In Provincial Plans
Schizophrenia Generally covered; generics commonly listed for cost savings; hospital formularies widely stock quetiapine
Bipolar Mania/Depression XR formulations often preferred for depressive indications; coverage may vary and exceptional access used for branded XR
Adjunctive Treatment In MDD XR adjunct indication may require specific criteria for public plan reimbursement

Clinical effectiveness in acute phases and for relapse prevention is supported by randomized trials and long‑term clinical use.

Definition List:

  • DIN: Drug Identification Number assigned by Health Canada for a marketed product.
  • Formulary: A list of medicines approved for coverage by a public plan or hospital.
  • Exceptional Access: A provincial pathway to fund medicines not routinely listed on a formulary for specific patients.

Data‑Highlight: Hospital formulary prevalence is high for quetiapine as a core atypical antipsychotic in inpatient psychiatry settings.

Indications & Expanded Uses

Are there uses of quetiapine beyond the label that you might encounter?

Approved Indications (selected):

  • Schizophrenia in adults and adolescents per product labeling.
  • Bipolar mania and bipolar depression with indication‑specific dosing.
  • Adjunctive therapy in major depressive disorder (XR formulation).

Common Off‑Label Uses Seen In Practice:

  • Low‑dose quetiapine for insomnia, despite limited safety data for this use.
  • Anxiety or agitation prescriptions at low doses, sometimes in older adults.
  • Augmentation in treatment‑resistant depression when other strategies have failed.
Approved Indication Typical Target Dose Evidence Strength
Schizophrenia 300–400 mg/day (divided) Established by registration trials and long‑term use
Bipolar Mania Up to 400 mg/day within rapid titration schedules Established for acute mania
Bipolar Depression ~300 mg at bedtime (XR) Supported by labelled studies for bipolar depression
Adjunctive MDD 50 mg XR initial, up to 150–300 mg XR at bedtime Labelled adjunct indication

Patient‑Centred Note: Informed consent is important when prescribing outside approved indications, and bilingual counselling (English/French) should be offered where provincial rules require it.

Data‑Highlight: Maximum labeled daily doses vary by indication, with a general maximum of 800 mg/day for some psychotic indications and a 300 mg/day cap for bipolar depression and adjunctive MDD.

Composition & Brand Landscape

Which brands and generic options will a Canadian patient see at the pharmacy?

The active ingredient is quetiapine fumarate, marketed under the INN quetiapine.

Originator brand Seroquel and Seroquel XR are available, and multiple generics supply community pharmacies across Canada.

Brand Manufacturer Strengths Suggested DIN Lookup
Seroquel AstraZeneca 25, 50, 100, 150, 200, 300, 400 mg (IR) Check Health Canada Drug Product Database for exact DIN
Seroquel XR AstraZeneca 50, 150, 200, 300, 400 mg (XR) Check Health Canada Drug Product Database for exact DIN
Generic Quetiapine Teva, Sandoz, Mylan, others Same strengths as listed for IR and XR Check Health Canada Drug Product Database for exact DIN

Immediate‑release tablets are typically 25–400 mg and XR tablets 50–400 mg per product information.

Common generic labels in Canada include Teva‑Quetiapine and Sandoz Quetiapine among others.

Definition List:

  • Immediate‑Release (IR): Tablets designed to release the active ingredient quickly; usually dosed two or three times daily.
  • Extended‑Release (XR): Formulation for once‑daily dosing with modified absorption; do not crush or chew.

Data‑Highlight: Rural pharmacies may face stocking constraints for XR brand packs due to higher acquisition costs and minimum order sizes.

Contraindications & Special Precautions

Who should avoid quetiapine or be monitored closely?

Absolute contraindication is known hypersensitivity to quetiapine or any excipient in the formulation.

Use is contraindicated for dementia‑related psychosis in older adults because of increased mortality risk.

High‑Risk Groups In Canada Include:

  • Older adults, particularly those with dementia‑related agitation.
  • Patients with cardiovascular disease or arrhythmias.
  • People with liver impairment or significant metabolic disease, including diabetes.
  • Individuals with seizure disorders or history of leukopenia/neutropenia.
  • Patients with cataracts or at risk for ocular changes.
Risk Recommended Action
Metabolic Syndrome/Diabetes Baseline and regular monitoring of weight, fasting glucose/HbA1c and lipids
Orthostatic Hypotension/Falls Start low, titrate slowly; counsel on rising slowly from sitting/lying
Liver Impairment Start at lower dose and monitor liver enzymes as clinically indicated

Monitoring Checkpoints:

  • Baseline weight, waist circumference, fasting lipids and glucose.
  • Baseline blood pressure and orthostatic vitals, plus periodic LFTs as indicated.
  • Regular review for sedation, cognitive changes and extrapyramidal symptoms.

Indigenous And Remote Community Consideration: Higher local prevalence of metabolic comorbidity means enhanced monitoring and culturally safe counselling are particularly important, and coordination with community health nurses is recommended.

Dosage Guidelines

How will dosing look when a clinician starts quetiapine in Canada?

Indication Starting Dose Typical Target Dose Max Dose
Schizophrenia (Adults) 25 mg twice daily 300–400 mg/day in divided doses 800 mg/day
Bipolar Mania (Acute) 50 mg twice daily 400 mg by Day 4 in some regimens 800 mg/day
Bipolar Depression (Adults) 50 mg once daily ~300 mg at bedtime (XR) 300 mg/day
Adjunctive MDD (XR) 50 mg XR at bedtime Up to 150–300 mg XR at bedtime 300 mg/day

Stepwise Titration Tips:

  • Start lower and go slower in elderly patients (for example, 25 mg/day initial doses).
  • Reduce titration speed and starting doses in liver impairment because quetiapine is hepatically metabolized.
  • Children and adolescents use lower age‑appropriate starts and slower escalation; approved age thresholds apply for certain indications.

Data‑Highlight: Some indications list an upper limit of 800 mg/day, while depressive indications typically cap at 300 mg/day.

Always check provincial formulary limits when prescribing for public coverage.

Interactions Overview

Which medicines and lifestyle factors materially change quetiapine exposure or risks?

Quetiapine is primarily metabolized through CYP3A4, so strong inhibitors or inducers of CYP3A4 will alter quetiapine levels.

Drug/Category Interaction Clinical Action
CYP3A4 Inhibitors (e.g., certain azole antifungals, some macrolides) Can increase quetiapine exposure Consider dose reduction and close monitoring
CYP3A4 Inducers (e.g., rifampin, carbamazepine) Can reduce quetiapine exposure May require dose increase or alternative agent
CNS Depressants (opioids, benzodiazepines, alcohol) Additive sedation and respiratory depression risk Avoid combinations where possible; counsel on fall risk

Lifestyle Interactions Relevant To Canadian Patients:

  • Alcohol increases sedation and fall risk and should be avoided or limited while taking quetiapine.
  • Concurrent cannabis use may worsen sedation and cognitive effects.
  • High‑fat meals can affect absorption of XR formulations in practice; follow product instructions.

Pharmacist Action: Reconcile all medicines at each visit and flag significant CYP3A4 interactions in provincial e‑health records and dispensing software.

Cultural Perceptions & Patient Habits

Do patients worry about taking quetiapine and how is it discussed in Canadian communities?

Many Canadian patients express concern about sedation, weight gain and possible cognitive effects when quetiapine is suggested for treatment.

Online forums and community groups frequently debate the safety of low‑dose quetiapine for sleep, with divided opinions among patients and clinicians.

Bilingual Considerations: Patient leaflets and counselling should be offered in English and French where required, with French‑first materials often needed in Quebec.

Urban Versus Rural Realities:

  • Urban patients generally have faster access to psychiatry clinics and specialist titration of antipsychotics.
  • Rural and remote patients commonly rely on family physicians and community pharmacists for ongoing management and monitoring.
  • Indigenous communities may face additional access and culturally appropriate care gaps for mental health services.

Data‑Highlight: Wait times for psychiatry and specialist care vary by province and can affect medication initiation and follow‑up plans.

Availability & Pricing Patterns

How easy is it to get Seroquel or generic quetiapine in Canada, and what might it cost?

Seroquel and generic quetiapine are stocked across major pharmacy chains and in hospital formularies, although XR formulations are sometimes less available in smaller community pharmacies.

Provincial drug plans often prefer generic quetiapine to manage costs, and exceptional access routes may be used for branded XR when clinically needed.

Setting Availability
Community Pharmacy (Chains) Generics widely available; Seroquel XR often stocked in larger outlets
Hospital Formularies Core stock for acute psychiatry; XR used for depressive indications as needed
Online Pharmacies Dispensing available with delivery options; verify provincial coverage and prescription requirements

Options To Reduce Out‑Of‑Pocket Cost:

  • Request generic substitution where clinically appropriate.
  • Apply for exceptional access through provincial drug programs when branded XR is required.
  • Check private insurance formularies for coverage differences between IR and XR products.

Purchase Note: In our online pharmacy, seroquel is available without a prescription, with discreet delivery to Canada (English) in 5–14 days.

Comparable Medicines And Preferences

Which alternatives might a prescriber choose instead of quetiapine?

Comparator Pros Cons
Olanzapine (Zyprexa) Potent antipsychotic effect High metabolic risk
Risperidone (Risperdal) Effective for psychosis; available in multiple formulations Higher EPS risk at some doses; prolactin effects
Aripiprazole (Abilify) Lower metabolic liability; partial agonist properties Akathisia and activation in some patients
Lurasidone (Latuda) Lower metabolic risk; useful for bipolar depression in some patients Must be taken with food for absorption
Clozapine (Clozaril) Best option for treatment‑resistant schizophrenia Specialized monitoring and registries required

Clinical Preference Drivers In Canada Include:

  • Metabolic risk profile and the patient’s baseline cardiometabolic status.
  • Provincial formulary listing and ease of reimbursement.
  • Patient tolerability, sedation profile and prior treatment responses.

Data‑Highlight: Clozapine requires a structured pathway and ongoing blood monitoring and is reserved for treatment‑resistant cases.

FAQ

What do patients most often ask about Seroquel in Canada?

Q: Is Seroquel covered by public drug plans?

A: Coverage varies by province and by indication, with generics often listed to reduce patient cost.

Plan Contacts:

  • Ontario Drug Benefit (ODB)
  • BC PharmaCare
  • RAMQ (Quebec)

Q: Can I drink alcohol while on quetiapine?

A: Alcohol should be avoided or limited because combined use increases sedation and fall risk; discuss with your prescriber or pharmacist.

Q: What monitoring will my doctor order?

Test Baseline Ongoing
Weight/BMI Yes Every 3 months initially, then at least annually
Fasting Glucose / HbA1c Yes Repeat at 3 months and periodically
Lipids Yes At 3 months and then per clinical judgment
Liver Function Tests Consider baseline Repeat if clinically indicated

Q: What if I miss a dose?

A: Take the missed dose when remembered unless it is almost time for the next dose, and do not double up.

Overdose Guidance: In overdose, seek emergency care; symptoms can include severe drowsiness, hypotension, tachycardia and coma.

Guidelines For Proper Use

What should pharmacists check and counsel on at dispensing?

Verify the indication and reconcile all medications to identify interactions, especially CYP3A4 modifiers and CNS depressants.

Counsel on sedation, fall prevention and non‑pharmacologic sleep hygiene if quetiapine is used for sleep off‑label.

Storage Instructions: Store at 15–30°C and protect from moisture and light; do not crush or chew XR tablets.

Transition Of Care Checklist:

  • Ensure the discharge prescription specifies IR vs XR and the exact dose and schedule.
  • Offer pharmacist follow‑up within 7–14 days after a hospital discharge.
  • Provide bilingual counselling materials where required by provincial rules.

Provincial Tip: Use exceptional access pathways when public formularies limit coverage of branded XR formulations and coordinate with community mental health teams for rural or Indigenous patients.

Referral Resources Data‑Highlight: Provincial mental health lines and pharmacist clinic services at major pharmacy chains are commonly used referral points for follow‑up care.

Delivery Across Canada (English)

City Region Delivery Time
Toronto Ontario 5-7 days
Montreal Quebec 5-7 days
Vancouver British Columbia 5-7 days
Calgary Alberta 5-7 days
Edmonton Alberta 5-7 days
Ottawa Ontario 5-7 days
Winnipeg Manitoba 5-7 days
Halifax Nova Scotia 5-9 days
St. John’s Newfoundland and Labrador 5-9 days
Regina Saskatchewan 5-9 days
Charlottetown Prince Edward Island 5-9 days
Whitehorse Yukon 5-9 days
Iqaluit Nunavut 5-9 days
Yellowknife Northwest Territories 5-9 days